Literature DB >> 11376622

Induction of atrial tachycardia and fibrillation in the mouse heart.

H Wakimoto1, C T Maguire, P Kovoor, P E Hammer, J Gehrmann, J K Triedman, C I Berul.   

Abstract

BACKGROUND: Atrial tachycardia and fibrillation in humans may be partly consequent to vagal stimulation. Induction of fibrillation in the small heart is considered to be impossible due to lack of a critical mass of > 100-200 mm2. Even with the recent progression of the technology of in vivo and in vitro mouse electrophysiological studies, few reports describe atrial tachycardia or fibrillation in mice. The purpose of this study was to attempt provocation of atrial tachyarrhythmia in mice using transvenous pacing following cholinergic stimulation. METHODS AND
RESULTS: In vivo electrophysiology studies were performed in 14 normal mice. A six-lead ECG was recorded from surface limb leads, and an octapolar electrode catheter was inserted via jugular vein cutdown approach for simultaneous atrial and ventricular endocardial recording and pacing. Atrial tachycardia and fibrillation were inducible in one mouse at baseline electrophysiology study and eleven of fourteen mice after carbamyl choline injection. The mean duration of atrial tachycardia was 126 +/- 384 s. The longest episode lasted 35 min and only terminated after atropine injection. Reinduction of atrial tachycardia after administration of atropine was not possible.
CONCLUSION: Despite the small mass of the normal mouse atria, sustained atrial tachycardia and fibrillation can be easily and reproducibly inducible with endocardial pacing after cholinergic agonist administration. This finding may contribute to our understanding of the classical theories of arrhythmogenesis and critical substrates necessary for sustaining microreentrant circuits. The techniques of transcatheter parasympathetic agonist-mediated atrial tachycardia induction may be valuable in further murine electrophysiological studies, especially mutant models with potential atrial arrhythmia phenotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376622     DOI: 10.1016/s0008-6363(01)00264-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  27 in total

1.  G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block.

Authors:  Pietro Mesirca; Isabelle Bidaud; François Briec; Stéphane Evain; Angelo G Torrente; Khai Le Quang; Anne-Laure Leoni; Matthias Baudot; Laurine Marger; Antony Chung You Chong; Joël Nargeot; Joerg Striessnig; Kevin Wickman; Flavien Charpentier; Matteo E Mangoni
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

2.  A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse.

Authors:  Maarten Hulsmans; Aaron D Aguirre; Matthew D Bonner; Aneesh Bapat; Sebastian Cremer; Yoshiko Iwamoto; Kevin R King; Filip K Swirski; David J Milan; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

Review 3.  A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation.

Authors:  Michael A Rosenberg; Saumya Das; Pablo Quintero Pinzon; Ashley C Knight; David E Sosnovik; Patrick T Ellinor; Anthony Rosenzweig
Journal:  J Atr Fibrillation       Date:  2012-02-02

Review 4.  Introducing Therioepistemology: the study of how knowledge is gained from animal research.

Authors:  Joseph P Garner; Brianna N Gaskill; Elin M Weber; Jamie Ahloy-Dallaire; Kathleen R Pritchett-Corning
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

5.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

Authors:  Mihail G Chelu; Satyam Sarma; Subeena Sood; Sufen Wang; Ralph J van Oort; Darlene G Skapura; Na Li; Marco Santonastasi; Frank Ulrich Müller; Wilhelm Schmitz; Ulrich Schotten; Mark E Anderson; Miguel Valderrábano; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

6.  Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.

Authors:  Laila Guzadhur; Sarah M Pearcey; Rudolf M Duehmke; Kamalan Jeevaratnam; Anja F Hohmann; Yanmin Zhang; Andrew A Grace; Ming Lei; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2010-06-16       Impact factor: 3.657

7.  Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

Authors:  Sander Verheule; Toshiaki Sato; Thomas Everett; Steven K Engle; Dan Otten; Michael Rubart-von der Lohe; Hisako O Nakajima; Hidehiro Nakajima; Loren J Field; Jeffrey E Olgin
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

8.  Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.

Authors:  Eun-Gyoung Hong; Brian W Kim; Dae Young Jung; Jong Hun Kim; Tim Yu; Wagner Seixas Da Silva; Randall H Friedline; Suzy D Bianco; Stephen P Seslar; Hiroko Wakimoto; Charles I Berul; Kerry S Russell; Ki Won Lee; P Reed Larsen; Antonio C Bianco; Jason K Kim
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

9.  Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation.

Authors:  Subeena Sood; Mihail G Chelu; Ralph J van Oort; Darlene Skapura; Marco Santonastasi; Dobromir Dobrev; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2008-03-27       Impact factor: 6.343

10.  Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers.

Authors:  Mark D Levin; Min Min Lu; Nataliya B Petrenko; Brian J Hawkins; Tara H Gupta; Deborah Lang; Peter T Buckley; Jeanine Jochems; Fang Liu; Christopher F Spurney; Li J Yuan; Jason T Jacobson; Christopher B Brown; Li Huang; Friedrich Beermann; Kenneth B Margulies; Muniswamy Madesh; James H Eberwine; Jonathan A Epstein; Vickas V Patel
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.